Acuitas Investments LLC reduced its position in Arteris, Inc. (NASDAQ:AIP - Free Report) by 24.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 107,250 shares of the company's stock after selling 34,622 shares during the quarter. Acuitas Investments LLC owned 0.27% of Arteris worth $1,093,000 as of its most recent SEC filing.
Other hedge funds also recently added to or reduced their stakes in the company. US Bancorp DE bought a new stake in Arteris during the 3rd quarter valued at $34,000. R Squared Ltd purchased a new position in Arteris in the fourth quarter valued at about $64,000. The Manufacturers Life Insurance Company purchased a new position in Arteris in the second quarter valued at about $86,000. MetLife Investment Management LLC raised its holdings in Arteris by 129.1% in the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company's stock worth $131,000 after purchasing an additional 9,551 shares in the last quarter. Finally, SG Americas Securities LLC purchased a new stake in shares of Arteris during the fourth quarter valued at about $134,000. 64.36% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several research analysts recently commented on AIP shares. Northland Securities boosted their price objective on shares of Arteris from $14.00 to $16.00 and gave the stock an "outperform" rating in a research note on Wednesday. Rosenblatt Securities reaffirmed a "buy" rating and set a $15.00 price target on shares of Arteris in a research report on Tuesday.
View Our Latest Analysis on AIP
Insider Activity at Arteris
In other news, VP Paul L. Alpern sold 3,326 shares of the firm's stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $12.35, for a total value of $41,076.10. Following the completion of the transaction, the vice president now directly owns 61,604 shares in the company, valued at $760,809.40. This trade represents a 5.12 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Isabelle F. Geday sold 15,550 shares of the company's stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $9.03, for a total value of $140,416.50. Following the completion of the sale, the director now owns 121,213 shares in the company, valued at approximately $1,094,553.39. This represents a 11.37 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 367,157 shares of company stock valued at $3,828,388 in the last ninety days. Company insiders own 33.70% of the company's stock.
Arteris Stock Down 5.8 %
Shares of AIP stock traded down $0.57 during trading hours on Friday, reaching $9.28. 329,535 shares of the company's stock were exchanged, compared to its average volume of 325,433. The stock has a market cap of $380.02 million, a PE ratio of -10.67 and a beta of 1.18. The company has a current ratio of 1.17, a quick ratio of 1.16 and a debt-to-equity ratio of 0.30. The stock's fifty day moving average price is $10.53 and its two-hundred day moving average price is $8.72. Arteris, Inc. has a 1 year low of $5.76 and a 1 year high of $12.64.
Arteris (NASDAQ:AIP - Get Free Report) last issued its quarterly earnings results on Tuesday, February 18th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.08). The company had revenue of $15.49 million for the quarter, compared to analyst estimates of $15.34 million. Arteris had a negative net margin of 58.27% and a negative return on equity of 828.71%. Research analysts predict that Arteris, Inc. will post -0.71 EPS for the current year.
Arteris Company Profile
(
Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Recommended Stories

Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.